Format

Send to

Choose Destination
Urology. 2019 Nov;133:11-15. doi: 10.1016/j.urology.2019.06.011. Epub 2019 Jun 21.

Healthcare Costs of Post-Prostate Biopsy Sepsis.

Author information

1
Department of Urology, Weill Cornell Medicine, New York, NY.
2
Weill Cornell Medical College, New York, NY.
3
Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, TN.
4
The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD.
5
Department of Health Services and Policy Research, Weill Cornell Medicine, New York, NY.
6
Department of Urology, Weill Cornell Medicine, New York, NY. Electronic address: jch9011@med.cornell.edu.

Abstract

Sepsis following transrectal prostate biopsy occurs in 2%-5% of cases and the risk is increasing. We performed a comprehensive literature search for the cost of post-prostate biopsy sepsis to define the potential cost savings of reducing infectious complications. Reporting of cost is varied and presents a challenge to interpretation. Length of hospitalization ranged from 1.1 to 14 days and the percent admitted to an ICU ranged from 1.1% to 25%. The estimated cost of sepsis post-prostate biopsy, adjusted for inflation, ranged from $8,672 to $19,100. Healthcare costs of treating post-biopsy infection are substantial. Our findings should guide payers and policymakers, especially in value-based care models.

PMID:
31229516
DOI:
10.1016/j.urology.2019.06.011
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center